Free Trial
NASDAQ:PETV

PetVivo 6/29/2023 Earnings Report

PetVivo logo
$0.56 +0.04 (+6.89%)
As of 03:29 PM Eastern

PetVivo EPS Results

Actual EPS
-$0.21
Consensus EPS
-$0.21
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

PetVivo Revenue Results

Actual Revenue
$0.13 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

PetVivo Announcement Details

Quarter
Time
During Market Hours
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

PetVivo's next earnings date is estimated for Thursday, June 26, 2025, based on past reporting schedules.

Conference Call Resources

PetVivo Earnings Headlines

PetVivo closes Series B Convertible Preferred Stock offering
Crypto’s crashing…but we’re still profiting
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess. The news is screaming fear. But while most traders watch their portfolios tank…
See More PetVivo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PetVivo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PetVivo and other key companies, straight to your email.

About PetVivo

PetVivo (NASDAQ:PETV), a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

View PetVivo Profile

More Earnings Resources from MarketBeat